本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.95
0.0000
成交量:1.67万
成交额:3.25万
市值:591.14万
市盈率:0.00
高:2.00
开:1.91
低:1.91
收:1.95
52周最高:12.30
52周最低:1.90
股本:303.15万
流通股本:214.25万
量比:0.59
换手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-977.1003
每股收益(LYR):-1,791.0249
净资产收益率:-211.37%
总资产收益率:-77.12%
市净率:1.22
市盈率(LYR):0.00

数据加载中...

2019/07/10

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/05/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

招股说明书

Registration statement for certain foreign private issuers
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]